نتایج جستجو برای: promoter hypermethylation

تعداد نتایج: 91616  

Journal: :PLoS ONE 2008
Vincenzo Calvanese Angelica Horrillo Abdelkrim Hmadcha Beatriz Suarez-Álvarez Agustín F. Fernandez Ester Lara Sara Casado Pablo Menendez Clara Bueno Javier Garcia-Castro Ruth Rubio Pablo Lapunzina Miguel Alaminos Lodovica Borghese Stefanie Terstegge Neil J. Harrison Harry D. Moore Oliver Brüstle Carlos Lopez-Larrea Peter W. Andrews Bernat Soria Manel Esteller Mario F. Fraga

Developmental genes are silenced in embryonic stem cells by a bivalent histone-based chromatin mark. It has been proposed that this mark also confers a predisposition to aberrant DNA promoter hypermethylation of tumor suppressor genes (TSGs) in cancer. We report here that silencing of a significant proportion of these TSGs in human embryonic and adult stem cells is associated with promoter DNA ...

Journal: :Annals of oncology : official journal of the European Society for Medical Oncology 2004
F Graziano F Arduini A Ruzzo A Mandolesi I Bearzi R Silva P Muretto E Testa D Mari M Magnani M Scartozzi S Cascinu

BACKGROUND Hypermethylation is studied as a new, relevant mechanism for silencing tumor suppressor genes. It is a potentially reversible epigenetic change and it is the target of novel anticancer compounds with demethylating activity. In this perspective, we investigated E-cadherin gene (CDH1) promoter hypermethylation in gastric carcinomas and its correlation with E-cadherin protein expression...

Journal: :Cancer research 2008
Angela H Ting Hiromu Suzuki Leslie Cope Kornel E Schuebel Byron H Lee Minoru Toyota Kohzoh Imai Yasuhisa Shinomura Takashi Tokino Stephen B Baylin

Promoter hypermethylation is a prevalent phenomenon, found in virtually all cancer types studied thus far, and accounts for tumor suppressor gene silencing in the absence of genetic mutations. The mechanism behind the establishment and maintenance of such aberrant hypermethylation has been under intense study. Here, we have uncovered a link between aberrant gene silencing associated with promot...

2013
Marta Mellai Angela Piazzi Valentina Caldera Laura Annovazzi Oriana Monzeglio Rebecca Senetta Paola Cassoni Davide Schiffer

The epithelial membrane protein 3 (EMP3) is a candidate tumor suppressor gene in the critical region 19q13.3 for several solid tumors, including tumors of the nervous systems. The aim of this study was to investigate the EMP3 promoter hypermethylation status in a series of 229 astrocytic and oligodendroglial tumors and in 16 GBM cell lines. The analysis was performed by methylation-specific PCR...

2013
Fazlur Rahman Talukdar Sankar Kumar Ghosh Ruhina Shirin Laskar Rosy Mondal

BACKGROUND Esophageal squamous cell carcinoma (ESCC) develops as a result of complex epigenetic, genetic and environmental interactions. Epigenetic changes like, promoter hypermethylation of multiple tumour suppressor genes are frequent events in cancer, and certain habit-related carcinogens are thought to be capable of inducing aberrant methylation. However, the effects of environmental carcin...

ایزدی, امیر, فرامرزی, حسین, مسلمی, الهام,

Background: The molecular studies indicate some of the genes in the promoter region itself, will undergo methylation. Methylation of CpG islands in the promoter region of that cause silence or reduced expression of genes involved in cell growth pathways, which are colorectal cancer causing agents. Detection of methylation status can be used as a marker for cancer diagnosis and prediction of dis...

Journal: :Cancer research 2008
Anna Potapova Amanda M Hoffman Andrew K Godwin Tahseen Al-Saleem Paul Cairns

The partner and localizer of BRCA2 (PALB2) gene was recently identified as a BRCA2-interacting protein and subsequently shown to be a Fanconi anemia gene (FANCN). Disease-associated point mutations resulting in protein truncation have been found in BRCA1/2 mutation-negative breast cancer families identifying PALB2 as a susceptibility gene for breast cancer. Aberrant promoter hypermethylation is...

Journal: :Histology and histopathology 2007
M Rastetter U Schagdarsurengin C Lahtz E Fiedler W Ch Marsch R Dammann P Helmbold

To investigate intra-tumoural coexistence and heterogeneity of aberrant promoter hypermethylation of different tumour suppressor genes in melanoma, we analyzed the intra-tumoural distribution of promoter methylation of RASSF1A, p16, DAPK, MGMT, and Rb in 339 assays of 34 tumours (15 melanoma primaries, 19 metastases) by methylation-specific PCR, correlation to histopathology and RASSF1A express...

Journal: :Asian Pacific journal of cancer prevention : APJCP 2012
Nidda Syeed Firdous Hussain Syed Akhtar Husain Mushtaq A Siddiqi

BACKGROUND Caveolin-1 (CAV-1), encoding the structural component of cellular caveolae, is a suggested tumor suppressor gene involved in cell signalling. Aberrant promoter methylation of CAV-1 is associated with inactivation of expression. We previously observed CAV-1 mutations in breast cancers and therefore devised this study to examine the hypermethylation status of the promoter region of CAV...

2004
Ajay Goel Christian N. Arnold Donna Niedzwiecki John M. Carethers Jeannette M. Dowell Linda Wasserman Carolyn Compton Robert J. Mayer Monica M. Bertagnolli Richard Boland

Loss of PTEN tumor suppressor function is observed in tumors of breast, prostate, thyroid, and endometrial origin. Allelic losses in the proximity of the PTEN locus (10q23) also occur in sporadic colorectal cancers (CRCs), but biallelic inactivation of this site has not been frequently demonstrated. We hypothesized that alternative mechanisms of PTEN allelic inactivation, such as promoter hyper...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید